Number of the records: 1  

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

  1. 1.
    SYSNO ASEP0368977
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAnti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
    Author(s) Keunen, O. (LU)
    Johansson, M. (SE)
    Oudin, A. (LU)
    Sanzey, M. (LU)
    Rahim, S. A. (LU)
    Fack, F. (LU)
    Thorsen, F. (NO)
    Taxt, T. (NO)
    Bartoš, M. (CZ)
    Jiřík, Radovan (UPT-D) RID, ORCID, SAI
    Miletic, H. (NO)
    Wang, J. (NO)
    Stieber, D. (LU)
    Stuhr, L. (NO)
    Moen, I. (NO)
    Rygh, C. B. (NO)
    Bjerkvig, R. (NO)
    Niclou, S. (LU)
    Number of authors18
    Source TitleProceedings of the National Academy of Sciences of the United States of America. - : National Academy of Sciences - ISSN 0027-8424
    Roč. 108, č. 9 (2011), s. 3749-3754
    Number of pages6 s.
    Languageeng - English
    CountryUS - United States
    Keywordsangiogenesis ; glioma ; metabolism ; perfusion
    Subject RIVFS - Medical Facilities ; Equipment
    CEZAV0Z20650511 - UPT-D (2005-2011)
    UT WOS000287844400057
    EID SCOPUS79952740612
    DOI10.1073/pnas.1014480108
    AnnotationBevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its effects on tumor burden, recurrence, and vascular physiology are unclear. We therefore determined the tumor response to bevacizumab at the phenotypic, physiological, and molecular level in a clinically relevant intracranial GBM xenograft model derived from patient tumor spheroids. Using anatomical and physiological magnetic resonance imaging (MRI), we show that bevacizumab causes a strong decrease in contrast enhancement while having only a marginal effect on tumor growth. Interestingly, dynamic contrast-enhanced MRI revealed a significant reduction of the vascular supply, as evidenced by a decrease in intratumoral blood flow and volume and, at the morphological level, by a strong reduction of large- and medium-sized blood vessels. Electron microscopy revealed fewer mitochondria in the treated tumor cells.
    WorkplaceInstitute of Scientific Instruments
    ContactMartina Šillerová, sillerova@ISIBrno.Cz, Tel.: 541 514 178
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.